Search results
Showing 256 to 270 of 1242 results for public health guidance
Holding our meetings in public supports our commitment to having processes in place that are rigorous, open, and transparent.
Holding our meetings in public supports our commitment to having processes in place that are rigorous, open, and transparent.
In development Reference number: GID-TA11836 Expected publication date: TBC
Agenda and papers of the NICE public board meeting on 20 May 2025
This quality standard covers care and support and services for children, young people and adults with a learning disability (or a learning disability and autism) and behaviour that challenges, and their families and carers. It describes high quality care in priority areas for improvement.
View quality statements for QS101Show all sections
Sections for QS101
- Quality statements
- Quality statement 1: Lead commissioner
- Quality statement 2: Annual health check
- Quality statement 3: Initial assessment of behaviour that challenges
- Quality statement 4: Named lead practitioner
- Quality statement 5: Involving families and carers
- Quality statement 6: Parent-training programmes
- Quality statement 7: Personalised daily activities
Transvaginal Ultrasound-Guided Radiofrequency Ablation (RFA) for Uterine Fibroids
Awaiting development Reference number: GID-HTG10171 Expected publication date: TBC
Awaiting development Reference number: GID-TA11040 Expected publication date: TBC
Middle meningeal artery embolisation for chronic subdural haematomas
In development Reference number: GID-HTG10869 Expected publication date: 19 November 2026
Awaiting development Reference number: GID-TA11705 Expected publication date: TBC
Awaiting development Reference number: GID-TA11404 Expected publication date: TBC
Awaiting development Reference number: GID-TA11691 Expected publication date: TBC
Awaiting development Reference number: GID-TA10833 Expected publication date: TBC
In development Reference number: GID-TA11963 Expected publication date: 13 January 2027
Agenda and papers of the NICE public board meeting on 17 July 2024
This quality standard covers the effective use of antimicrobial medicines (including antibiotics) to reduce the risk of antimicrobial resistance, which is when antimicrobial medicines lose their effectiveness. It covers all settings and all types of antimicrobials for treating bacterial, fungal, viral and parasitic infections. It describes high-quality care in priority areas for improvement.
View quality statements for QS121Show all sections
Sections for QS121
- Quality statements
- Quality statement 1: Advice on self-limiting conditions
- Quality statement 2: Back-up (delayed) prescribing
- Quality statement 3: Recording information
- Quality statement 4: Microbiological samples
- Quality statement 5: Data collection and feedback
- Quality statement 6 (developmental statement): electronic prescribing systems
- Update information